Live Quote · AMEXVNRXHealthcare· Medical - Specialties

VolitionRX Ltd

$1.40 2.94%(+$0.04)
TickerSpark Score
56/100
Mixed
50
Valuation
60
Profitability
100
Growth
40
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a VNRX research report →

52-Week Range2% of range
Low
$1.17
Current
$1.40
High
$16.00
Company Overviewvolition.com

About the company

VolitionRx Limited, a multi-national epigenetics company, develops blood tests to help detect and monitor a range of cancers, and diseases associated with NETosis in the United States, Europe, and Asia. The company offers Nu. Q Vet, a cancer screening test for dogs and other animals; Nu.

CEO
Cameron Reynolds
IPO
2012
Employees
67
HQ
Henderson, NV, US

Price Chart

-90.69% · this period
$15.50$8.36$1.21Jul 02Dec 31Jul 02
Valuation
Market Cap
$11.68M
P/E
-0.33
P/S
4.74
P/B
-0.30
EV/EBITDA
-0.97
Div Yield
0.00%
Profitability
Gross Margin
89.68%
Op Margin
-870.98%
Net Margin
-997.46%
ROE
74.16%
ROIC
8712.40%
Growth & Income
Revenue
$1.73M · 40.04%
Net Income
$-23,357,027 · 13.39%
EPS
$-4.40 · 29.03%
Op Income
$-21,222,056
FCF YoY
25.29%
Performance & Tape
52W High
$16.00
52W Low
$1.17
50D MA
$2.09
200D MA
$5.34
Beta
1.11
Avg Volume
283.13K

Get TickerSpark's AI analysis on VNRX

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
Mar 17, 26Forterre Gaelother5,251
Mar 17, 26Rootsaert Rodney Gerardother3,948
Mar 17, 26Micallef Jacob Vincentother5,310
Mar 17, 26Plummer Nicholasother7,003
Mar 1, 26Rootsaert Rodney Gerardother3,321
Mar 1, 26Forterre Gaelother2,283
Mar 1, 26Plummer Nicholasother5,867
Feb 26, 26Forterre Gaelother149,000
Feb 26, 26Rubin Ethelother178,000
Feb 26, 26Reynolds Cameron Johnother486,000
Coverage · VNRX

Our VNRX coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on VNRX yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate VNRX report →
Internal Compare

Similar companies

Peers in the same neighborhood.